nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—migraine—Prednisone—prostate cancer	0.114	0.508	CpDpCtD
Diclofenac—osteoarthritis—Prednisone—prostate cancer	0.11	0.492	CpDpCtD
Diclofenac—CYP2C18—prostate cancer	0.0636	0.259	CbGaD
Diclofenac—CXCL8—prostate cancer	0.0609	0.247	CbGaD
Diclofenac—CYP2E1—prostate cancer	0.0288	0.117	CbGaD
Diclofenac—CYP2C19—prostate cancer	0.0285	0.116	CbGaD
Diclofenac—CYP1A1—prostate cancer	0.0284	0.115	CbGaD
Diclofenac—SLCO1C1—Conjugated Estrogens—prostate cancer	0.0182	0.0581	CbGbCtD
Diclofenac—CYP3A4—prostate cancer	0.0181	0.0737	CbGaD
Diclofenac—PTGS2—prostate cancer	0.0178	0.0722	CbGaD
Diclofenac—SLCO1C1—Estradiol—prostate cancer	0.016	0.051	CbGbCtD
Diclofenac—ABCC1—Abiraterone—prostate cancer	0.0149	0.0474	CbGbCtD
Diclofenac—SLC22A11—Conjugated Estrogens—prostate cancer	0.00941	0.03	CbGbCtD
Diclofenac—CYP1A1—Flutamide—prostate cancer	0.00919	0.0293	CbGbCtD
Diclofenac—ABCC4—Conjugated Estrogens—prostate cancer	0.00876	0.0279	CbGbCtD
Diclofenac—SLC22A11—Estradiol—prostate cancer	0.00826	0.0263	CbGbCtD
Diclofenac—UGT1A1—Estradiol—prostate cancer	0.00752	0.0239	CbGbCtD
Diclofenac—UGT2B7—Epirubicin—prostate cancer	0.00729	0.0232	CbGbCtD
Diclofenac—ABCC1—Conjugated Estrogens—prostate cancer	0.00704	0.0224	CbGbCtD
Diclofenac—ALB—Abiraterone—prostate cancer	0.00686	0.0219	CbGbCtD
Diclofenac—CYP1A1—Estrone—prostate cancer	0.00665	0.0212	CbGbCtD
Diclofenac—CYP2C8—Nilutamide—prostate cancer	0.0064	0.0204	CbGbCtD
Diclofenac—ABCC1—Mitoxantrone—prostate cancer	0.0064	0.0204	CbGbCtD
Diclofenac—SLC22A8—Conjugated Estrogens—prostate cancer	0.00547	0.0174	CbGbCtD
Diclofenac—CYP2C19—Bicalutamide—prostate cancer	0.00537	0.0171	CbGbCtD
Diclofenac—CYP2C19—Nilutamide—prostate cancer	0.00537	0.0171	CbGbCtD
Diclofenac—CYP2C8—Abiraterone—prostate cancer	0.0053	0.0169	CbGbCtD
Diclofenac—ABCC1—Epirubicin—prostate cancer	0.00518	0.0165	CbGbCtD
Diclofenac—CYP2E1—Estrone—prostate cancer	0.00513	0.0163	CbGbCtD
Diclofenac—CYP2B6—Estrone—prostate cancer	0.00506	0.0161	CbGbCtD
Diclofenac—ALB—Estrone—prostate cancer	0.00496	0.0158	CbGbCtD
Diclofenac—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00494	0.0157	CbGbCtD
Diclofenac—UGT1A1—Etoposide—prostate cancer	0.00491	0.0156	CbGbCtD
Diclofenac—SLC22A8—Estradiol—prostate cancer	0.0048	0.0153	CbGbCtD
Diclofenac—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00451	0.0144	CbGbCtD
Diclofenac—CYP2C9—Nilutamide—prostate cancer	0.00447	0.0142	CbGbCtD
Diclofenac—CYP2C9—Bicalutamide—prostate cancer	0.00447	0.0142	CbGbCtD
Diclofenac—CYP2C19—Flutamide—prostate cancer	0.00445	0.0142	CbGbCtD
Diclofenac—CYP1A2—Flutamide—prostate cancer	0.00411	0.0131	CbGbCtD
Diclofenac—ABCC1—Etoposide—prostate cancer	0.00403	0.0129	CbGbCtD
Diclofenac—ABCB1—Estramustine—prostate cancer	0.00403	0.0128	CbGbCtD
Diclofenac—CYP2C8—Cabazitaxel—prostate cancer	0.00392	0.0125	CbGbCtD
Diclofenac—CYP1A1—Estradiol—prostate cancer	0.00382	0.0122	CbGbCtD
Diclofenac—SLC22A6—Conjugated Estrogens—prostate cancer	0.00381	0.0121	CbGbCtD
Diclofenac—ABCC1—Docetaxel—prostate cancer	0.00369	0.0118	CbGbCtD
Diclofenac—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00342	0.0109	CbGbCtD
Diclofenac—CYP2E1—Mitoxantrone—prostate cancer	0.00305	0.00972	CbGbCtD
Diclofenac—CYP1A2—Estrone—prostate cancer	0.00297	0.00946	CbGbCtD
Diclofenac—PTGS2—Etoposide—prostate cancer	0.00295	0.0094	CbGbCtD
Diclofenac—ALB—Estradiol—prostate cancer	0.00285	0.00908	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—prostate cancer	0.00275	0.00876	CbGbCtD
Diclofenac—CYP2C9—Estrone—prostate cancer	0.00268	0.00852	CbGbCtD
Diclofenac—ABCB1—Cabazitaxel—prostate cancer	0.00266	0.00846	CbGbCtD
Diclofenac—CYP3A4—Bicalutamide—prostate cancer	0.0026	0.00827	CbGbCtD
Diclofenac—ABCB1—Estrone—prostate cancer	0.0026	0.00827	CbGbCtD
Diclofenac—PTGS1—Etoposide—prostate cancer	0.00249	0.00794	CbGbCtD
Diclofenac—ALB—Prednisone—prostate cancer	0.00245	0.00781	CbGbCtD
Diclofenac—CYP3A4—Estramustine—prostate cancer	0.00241	0.00769	CbGbCtD
Diclofenac—ABCB1—Ethinyl Estradiol—prostate cancer	0.00231	0.00737	CbGbCtD
Diclofenac—CYP2C8—Estradiol—prostate cancer	0.0022	0.00702	CbGbCtD
Diclofenac—CYP3A4—Flutamide—prostate cancer	0.00215	0.00685	CbGbCtD
Diclofenac—CYP3A4—Abiraterone—prostate cancer	0.00215	0.00685	CbGbCtD
Diclofenac—CYP2C9—Capecitabine—prostate cancer	0.00203	0.00646	CbGbCtD
Diclofenac—CYP1A2—Conjugated Estrogens—prostate cancer	0.00194	0.00619	CbGbCtD
Diclofenac—CYP2E1—Etoposide—prostate cancer	0.00193	0.00613	CbGbCtD
Diclofenac—CYP2C19—Estradiol—prostate cancer	0.00185	0.00589	CbGbCtD
Diclofenac—CYP1A2—Estradiol—prostate cancer	0.00171	0.00543	CbGbCtD
Diclofenac—ABCB1—Conjugated Estrogens—prostate cancer	0.0017	0.00541	CbGbCtD
Diclofenac—CYP3A4—Cabazitaxel—prostate cancer	0.00159	0.00507	CbGbCtD
Diclofenac—CYP2C19—Prednisone—prostate cancer	0.00159	0.00506	CbGbCtD
Diclofenac—TTR—urine—prostate cancer	0.00159	0.0494	CbGeAlD
Diclofenac—CYP3A4—Estrone—prostate cancer	0.00156	0.00495	CbGbCtD
Diclofenac—ABCB1—Mitoxantrone—prostate cancer	0.00154	0.00492	CbGbCtD
Diclofenac—CYP2C9—Estradiol—prostate cancer	0.00154	0.00489	CbGbCtD
Diclofenac—UGT1A1—urine—prostate cancer	0.0015	0.0468	CbGeAlD
Diclofenac—ABCB1—Estradiol—prostate cancer	0.00149	0.00475	CbGbCtD
Diclofenac—CYP2C8—Etoposide—prostate cancer	0.00144	0.00458	CbGbCtD
Diclofenac—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00139	0.00442	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—prostate cancer	0.0013	0.00413	CbGbCtD
Diclofenac—ABCB1—Prednisone—prostate cancer	0.00128	0.00408	CbGbCtD
Diclofenac—ASIC1—prostate gland—prostate cancer	0.00125	0.039	CbGeAlD
Diclofenac—CYP1A2—Etoposide—prostate cancer	0.00111	0.00355	CbGbCtD
Diclofenac—CXCR1—bone marrow—prostate cancer	0.00108	0.0338	CbGeAlD
Diclofenac—CYP3A4—Conjugated Estrogens—prostate cancer	0.00102	0.00324	CbGbCtD
Diclofenac—ABCB1—Etoposide—prostate cancer	0.000974	0.0031	CbGbCtD
Diclofenac—SLC22A8—urine—prostate cancer	0.000972	0.0303	CbGeAlD
Diclofenac—CYP3A4—Mitoxantrone—prostate cancer	0.000925	0.00295	CbGbCtD
Diclofenac—CYP3A4—Estradiol—prostate cancer	0.000893	0.00285	CbGbCtD
Diclofenac—ABCB1—Docetaxel—prostate cancer	0.000891	0.00284	CbGbCtD
Diclofenac—CYP2C19—urine—prostate cancer	0.000815	0.0254	CbGeAlD
Diclofenac—CYP3A4—Prednisone—prostate cancer	0.000768	0.00245	CbGbCtD
Diclofenac—PLA2G2A—prostate gland—prostate cancer	0.000754	0.0235	CbGeAlD
Diclofenac—CXCL8—prostate gland—prostate cancer	0.000747	0.0232	CbGeAlD
Diclofenac—CXCR1—lymph node—prostate cancer	0.000672	0.0209	CbGeAlD
Diclofenac—CYP1A2—urine—prostate cancer	0.000666	0.0207	CbGeAlD
Diclofenac—ABCB1—Doxorubicin—prostate cancer	0.000664	0.00211	CbGbCtD
Diclofenac—PLA2G2A—seminal vesicle—prostate cancer	0.000638	0.0199	CbGeAlD
Diclofenac—UGT2B7—prostate gland—prostate cancer	0.000635	0.0198	CbGeAlD
Diclofenac—CYP2C9—urine—prostate cancer	0.000632	0.0197	CbGeAlD
Diclofenac—CYP2E1—urine—prostate cancer	0.000599	0.0186	CbGeAlD
Diclofenac—SCN4A—prostate gland—prostate cancer	0.000585	0.0182	CbGeAlD
Diclofenac—CYP3A4—Etoposide—prostate cancer	0.000583	0.00186	CbGbCtD
Diclofenac—PLA2G2A—epithelium—prostate cancer	0.000554	0.0173	CbGeAlD
Diclofenac—ASIC1—testis—prostate cancer	0.000551	0.0172	CbGeAlD
Diclofenac—UGT1A1—prostate gland—prostate cancer	0.00054	0.0168	CbGeAlD
Diclofenac—CYP3A4—Docetaxel—prostate cancer	0.000534	0.0017	CbGbCtD
Diclofenac—ALOX5—prostate gland—prostate cancer	0.000516	0.0161	CbGeAlD
Diclofenac—PLA2G2A—renal system—prostate cancer	0.000514	0.016	CbGeAlD
Diclofenac—PLA2G2A—urethra—prostate cancer	0.000505	0.0157	CbGeAlD
Diclofenac—CXCL8—urethra—prostate cancer	0.0005	0.0156	CbGeAlD
Diclofenac—CYP3A4—urine—prostate cancer	0.000482	0.015	CbGeAlD
Diclofenac—SLCO1C1—renal system—prostate cancer	0.000434	0.0135	CbGeAlD
Diclofenac—UGT2B7—renal system—prostate cancer	0.000433	0.0135	CbGeAlD
Diclofenac—SLC22A11—renal system—prostate cancer	0.000422	0.0131	CbGeAlD
Diclofenac—Lorazepam—UGT2B15—prostate cancer	0.000417	0.19	CrCbGaD
Diclofenac—KCNQ2—testis—prostate cancer	0.000403	0.0126	CbGeAlD
Diclofenac—ASIC1—lymph node—prostate cancer	0.0004	0.0124	CbGeAlD
Diclofenac—SCN4A—renal system—prostate cancer	0.000399	0.0124	CbGeAlD
Diclofenac—CYP3A4—Doxorubicin—prostate cancer	0.000398	0.00127	CbGbCtD
Diclofenac—TTR—renal system—prostate cancer	0.000388	0.0121	CbGeAlD
Diclofenac—CXCL8—bone marrow—prostate cancer	0.000385	0.012	CbGeAlD
Diclofenac—UGT1A1—renal system—prostate cancer	0.000368	0.0115	CbGeAlD
Diclofenac—ABCC4—prostate gland—prostate cancer	0.000352	0.011	CbGeAlD
Diclofenac—SLC22A8—prostate gland—prostate cancer	0.000349	0.0109	CbGeAlD
Diclofenac—ALOX5—urethra—prostate cancer	0.000345	0.0108	CbGeAlD
Diclofenac—PLA2G2A—testis—prostate cancer	0.000332	0.0103	CbGeAlD
Diclofenac—CXCL8—testis—prostate cancer	0.000329	0.0102	CbGeAlD
Diclofenac—Meclofenamic acid—AKR1C3—prostate cancer	0.000316	0.144	CrCbGaD
Diclofenac—ABCC1—prostate gland—prostate cancer	0.0003	0.00934	CbGeAlD
Diclofenac—TTR—bone marrow—prostate cancer	0.000293	0.00914	CbGeAlD
Diclofenac—SLCO1C1—testis—prostate cancer	0.000281	0.00874	CbGeAlD
Diclofenac—UGT2B7—testis—prostate cancer	0.00028	0.00871	CbGeAlD
Diclofenac—ALOX5—bone marrow—prostate cancer	0.000266	0.00828	CbGeAlD
Diclofenac—SCN4A—testis—prostate cancer	0.000258	0.00803	CbGeAlD
Diclofenac—ABCC1—seminal vesicle—prostate cancer	0.000254	0.0079	CbGeAlD
Diclofenac—TTR—testis—prostate cancer	0.000251	0.00781	CbGeAlD
Diclofenac—Mefenamic acid—AKR1C3—prostate cancer	0.000245	0.112	CrCbGaD
Diclofenac—PLA2G2A—lymph node—prostate cancer	0.000241	0.0075	CbGeAlD
Diclofenac—ABCC4—renal system—prostate cancer	0.00024	0.00747	CbGeAlD
Diclofenac—CXCL8—lymph node—prostate cancer	0.000238	0.00742	CbGeAlD
Diclofenac—SLC22A8—renal system—prostate cancer	0.000238	0.00741	CbGeAlD
Diclofenac—ALOX5—testis—prostate cancer	0.000227	0.00708	CbGeAlD
Diclofenac—CYP2E1—prostate gland—prostate cancer	0.000215	0.00669	CbGeAlD
Diclofenac—PTGS1—prostate gland—prostate cancer	0.000207	0.00645	CbGeAlD
Diclofenac—SLCO1C1—lymph node—prostate cancer	0.000203	0.00633	CbGeAlD
Diclofenac—ABCC1—urethra—prostate cancer	0.000201	0.00625	CbGeAlD
Diclofenac—PTGS2—prostate gland—prostate cancer	0.000198	0.00616	CbGeAlD
Diclofenac—Clonidine—SLC22A3—prostate cancer	0.000187	0.0853	CrCbGaD
Diclofenac—CYP2E1—seminal vesicle—prostate cancer	0.000182	0.00566	CbGeAlD
Diclofenac—ABCC4—bone marrow—prostate cancer	0.000181	0.00564	CbGeAlD
Diclofenac—PTGS1—seminal vesicle—prostate cancer	0.000175	0.00545	CbGeAlD
Diclofenac—CYP2C8—renal system—prostate cancer	0.000174	0.00542	CbGeAlD
Diclofenac—CYP1A1—epithelium—prostate cancer	0.000173	0.00539	CbGeAlD
Diclofenac—PTGS2—seminal vesicle—prostate cancer	0.000167	0.00521	CbGeAlD
Diclofenac—ALOX5—lymph node—prostate cancer	0.000165	0.00513	CbGeAlD
Diclofenac—CYP1A2—renal system—prostate cancer	0.000163	0.00507	CbGeAlD
Diclofenac—CYP1A1—renal system—prostate cancer	0.000161	0.005	CbGeAlD
Diclofenac—ALB—testis—prostate cancer	0.00016	0.00498	CbGeAlD
Diclofenac—CYP1A1—urethra—prostate cancer	0.000158	0.00491	CbGeAlD
Diclofenac—CYP2B6—renal system—prostate cancer	0.000156	0.00486	CbGeAlD
Diclofenac—ABCC4—testis—prostate cancer	0.000155	0.00483	CbGeAlD
Diclofenac—PTGS1—epithelium—prostate cancer	0.000152	0.00474	CbGeAlD
Diclofenac—CYP2E1—renal system—prostate cancer	0.000147	0.00456	CbGeAlD
Diclofenac—PTGS2—epithelium—prostate cancer	0.000145	0.00453	CbGeAlD
Diclofenac—CYP2E1—urethra—prostate cancer	0.000144	0.00448	CbGeAlD
Diclofenac—PTGS1—renal system—prostate cancer	0.000141	0.0044	CbGeAlD
Diclofenac—Guanfacine—CYP2C19—prostate cancer	0.00014	0.0639	CrCbGaD
Diclofenac—PTGS2—renal system—prostate cancer	0.000135	0.0042	CbGeAlD
Diclofenac—Clonidine—SLC22A1—prostate cancer	0.000134	0.0612	CrCbGaD
Diclofenac—PTGS2—urethra—prostate cancer	0.000133	0.00413	CbGeAlD
Diclofenac—ABCC1—testis—prostate cancer	0.000132	0.00411	CbGeAlD
Diclofenac—ABCB1—prostate gland—prostate cancer	0.000122	0.00381	CbGeAlD
Diclofenac—CYP3A4—renal system—prostate cancer	0.000118	0.00367	CbGeAlD
Diclofenac—ALB—lymph node—prostate cancer	0.000116	0.00361	CbGeAlD
Diclofenac—Lumiracoxib—CYP2C19—prostate cancer	0.000114	0.0521	CrCbGaD
Diclofenac—CYP2C8—testis—prostate cancer	0.000112	0.0035	CbGeAlD
Diclofenac—ABCC4—lymph node—prostate cancer	0.000112	0.0035	CbGeAlD
Diclofenac—Clonidine—CYP3A5—prostate cancer	0.000108	0.0493	CrCbGaD
Diclofenac—ABCB1—seminal vesicle—prostate cancer	0.000104	0.00322	CbGeAlD
Diclofenac—PTGS2—bone marrow—prostate cancer	0.000102	0.00318	CbGeAlD
Diclofenac—CYP2B6—testis—prostate cancer	0.000101	0.00314	CbGeAlD
Diclofenac—ABCC1—lymph node—prostate cancer	9.58e-05	0.00298	CbGeAlD
Diclofenac—CYP2E1—testis—prostate cancer	9.47e-05	0.00295	CbGeAlD
Diclofenac—PTGS1—testis—prostate cancer	9.12e-05	0.00284	CbGeAlD
Diclofenac—ABCB1—epithelium—prostate cancer	9e-05	0.0028	CbGeAlD
Diclofenac—Guanfacine—CYP3A4—prostate cancer	8.9e-05	0.0407	CrCbGaD
Diclofenac—Bromfenac—PTGS2—prostate cancer	8.35e-05	0.0382	CrCbGaD
Diclofenac—ABCB1—renal system—prostate cancer	8.35e-05	0.0026	CbGeAlD
Diclofenac—ABCB1—urethra—prostate cancer	8.2e-05	0.00255	CbGeAlD
Diclofenac—CYP1A1—lymph node—prostate cancer	7.53e-05	0.00234	CbGeAlD
Diclofenac—Clonidine—CYP1A1—prostate cancer	7.32e-05	0.0335	CrCbGaD
Diclofenac—Lumiracoxib—PTGS2—prostate cancer	7.1e-05	0.0325	CrCbGaD
Diclofenac—Nepafenac—PTGS2—prostate cancer	6.76e-05	0.0309	CrCbGaD
Diclofenac—PTGS1—lymph node—prostate cancer	6.61e-05	0.00206	CbGeAlD
Diclofenac—PTGS2—lymph node—prostate cancer	6.32e-05	0.00197	CbGeAlD
Diclofenac—ABCB1—bone marrow—prostate cancer	6.31e-05	0.00196	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—prostate cancer	5.53e-05	0.0253	CrCbGaD
Diclofenac—ABCB1—testis—prostate cancer	5.39e-05	0.00168	CbGeAlD
Diclofenac—Clonidine—CYP3A4—prostate cancer	4.68e-05	0.0214	CrCbGaD
Diclofenac—Mefenamic acid—PTGS2—prostate cancer	4.3e-05	0.0197	CrCbGaD
Diclofenac—ABCB1—lymph node—prostate cancer	3.91e-05	0.00122	CbGeAlD
Diclofenac—Tinnitus—Epirubicin—prostate cancer	1.17e-05	0.000114	CcSEcCtD
Diclofenac—Haemoglobin—Doxorubicin—prostate cancer	1.16e-05	0.000114	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.16e-05	0.000114	CcSEcCtD
Diclofenac—Flushing—Epirubicin—prostate cancer	1.16e-05	0.000114	CcSEcCtD
Diclofenac—Cardiac disorder—Epirubicin—prostate cancer	1.16e-05	0.000114	CcSEcCtD
Diclofenac—Rhinitis—Doxorubicin—prostate cancer	1.16e-05	0.000114	CcSEcCtD
Diclofenac—Dyspepsia—Docetaxel—prostate cancer	1.16e-05	0.000114	CcSEcCtD
Diclofenac—Haemorrhage—Doxorubicin—prostate cancer	1.16e-05	0.000113	CcSEcCtD
Diclofenac—Hepatitis—Doxorubicin—prostate cancer	1.16e-05	0.000113	CcSEcCtD
Diclofenac—Insomnia—Capecitabine—prostate cancer	1.15e-05	0.000113	CcSEcCtD
Diclofenac—Hypoaesthesia—Doxorubicin—prostate cancer	1.15e-05	0.000113	CcSEcCtD
Diclofenac—Pharyngitis—Doxorubicin—prostate cancer	1.15e-05	0.000113	CcSEcCtD
Diclofenac—Paraesthesia—Capecitabine—prostate cancer	1.14e-05	0.000112	CcSEcCtD
Diclofenac—Decreased appetite—Docetaxel—prostate cancer	1.14e-05	0.000112	CcSEcCtD
Diclofenac—Urinary tract disorder—Doxorubicin—prostate cancer	1.14e-05	0.000112	CcSEcCtD
Diclofenac—Oedema peripheral—Doxorubicin—prostate cancer	1.14e-05	0.000112	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Docetaxel—prostate cancer	1.14e-05	0.000111	CcSEcCtD
Diclofenac—Asthenia—Etoposide—prostate cancer	1.14e-05	0.000111	CcSEcCtD
Diclofenac—Dyspnoea—Capecitabine—prostate cancer	1.14e-05	0.000111	CcSEcCtD
Diclofenac—Oedema—Prednisone—prostate cancer	1.14e-05	0.000111	CcSEcCtD
Diclofenac—Anaphylactic shock—Prednisone—prostate cancer	1.14e-05	0.000111	CcSEcCtD
Diclofenac—Fatigue—Docetaxel—prostate cancer	1.14e-05	0.000111	CcSEcCtD
Diclofenac—Angiopathy—Epirubicin—prostate cancer	1.13e-05	0.000111	CcSEcCtD
Diclofenac—Urethral disorder—Doxorubicin—prostate cancer	1.13e-05	0.000111	CcSEcCtD
Diclofenac—Nausea—Mitoxantrone—prostate cancer	1.13e-05	0.000111	CcSEcCtD
Diclofenac—Immune system disorder—Epirubicin—prostate cancer	1.13e-05	0.000111	CcSEcCtD
Diclofenac—Infection—Prednisone—prostate cancer	1.13e-05	0.000111	CcSEcCtD
Diclofenac—Mediastinal disorder—Epirubicin—prostate cancer	1.13e-05	0.00011	CcSEcCtD
Diclofenac—Constipation—Docetaxel—prostate cancer	1.13e-05	0.00011	CcSEcCtD
Diclofenac—Pain—Docetaxel—prostate cancer	1.13e-05	0.00011	CcSEcCtD
Diclofenac—Dyspepsia—Capecitabine—prostate cancer	1.12e-05	0.00011	CcSEcCtD
Diclofenac—Chills—Epirubicin—prostate cancer	1.12e-05	0.00011	CcSEcCtD
Diclofenac—Pruritus—Etoposide—prostate cancer	1.12e-05	0.00011	CcSEcCtD
Diclofenac—Shock—Prednisone—prostate cancer	1.12e-05	0.00011	CcSEcCtD
Diclofenac—Arrhythmia—Epirubicin—prostate cancer	1.12e-05	0.00011	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—prostate cancer	1.11e-05	0.000109	CcSEcCtD
Diclofenac—Nervous system disorder—Prednisone—prostate cancer	1.11e-05	0.000109	CcSEcCtD
Diclofenac—Tachycardia—Prednisone—prostate cancer	1.11e-05	0.000109	CcSEcCtD
Diclofenac—Decreased appetite—Capecitabine—prostate cancer	1.11e-05	0.000109	CcSEcCtD
Diclofenac—Alopecia—Epirubicin—prostate cancer	1.1e-05	0.000108	CcSEcCtD
Diclofenac—Skin disorder—Prednisone—prostate cancer	1.1e-05	0.000108	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Capecitabine—prostate cancer	1.1e-05	0.000108	CcSEcCtD
Diclofenac—Fatigue—Capecitabine—prostate cancer	1.1e-05	0.000108	CcSEcCtD
Diclofenac—Hyperhidrosis—Prednisone—prostate cancer	1.1e-05	0.000108	CcSEcCtD
Diclofenac—Mental disorder—Epirubicin—prostate cancer	1.1e-05	0.000107	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—prostate cancer	1.09e-05	0.000107	CcSEcCtD
Diclofenac—Constipation—Capecitabine—prostate cancer	1.09e-05	0.000107	CcSEcCtD
Diclofenac—Pain—Capecitabine—prostate cancer	1.09e-05	0.000107	CcSEcCtD
Diclofenac—Erythema—Epirubicin—prostate cancer	1.09e-05	0.000107	CcSEcCtD
Diclofenac—Malnutrition—Epirubicin—prostate cancer	1.09e-05	0.000107	CcSEcCtD
Diclofenac—Feeling abnormal—Docetaxel—prostate cancer	1.08e-05	0.000106	CcSEcCtD
Diclofenac—Diarrhoea—Etoposide—prostate cancer	1.08e-05	0.000106	CcSEcCtD
Diclofenac—Anorexia—Prednisone—prostate cancer	1.08e-05	0.000106	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—prostate cancer	1.08e-05	0.000106	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—prostate cancer	1.08e-05	0.000106	CcSEcCtD
Diclofenac—Gastrointestinal pain—Docetaxel—prostate cancer	1.08e-05	0.000106	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—prostate cancer	1.07e-05	0.000105	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—prostate cancer	1.07e-05	0.000105	CcSEcCtD
Diclofenac—Flatulence—Epirubicin—prostate cancer	1.07e-05	0.000105	CcSEcCtD
Diclofenac—Tension—Epirubicin—prostate cancer	1.07e-05	0.000105	CcSEcCtD
Diclofenac—Dysgeusia—Epirubicin—prostate cancer	1.07e-05	0.000104	CcSEcCtD
Diclofenac—Nervousness—Epirubicin—prostate cancer	1.06e-05	0.000104	CcSEcCtD
Diclofenac—Back pain—Epirubicin—prostate cancer	1.05e-05	0.000103	CcSEcCtD
Diclofenac—Feeling abnormal—Capecitabine—prostate cancer	1.05e-05	0.000103	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—prostate cancer	1.05e-05	0.000103	CcSEcCtD
Diclofenac—Dizziness—Etoposide—prostate cancer	1.05e-05	0.000103	CcSEcCtD
Diclofenac—Muscle spasms—Epirubicin—prostate cancer	1.05e-05	0.000103	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—prostate cancer	1.04e-05	0.000102	CcSEcCtD
Diclofenac—Gastrointestinal pain—Capecitabine—prostate cancer	1.04e-05	0.000102	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—prostate cancer	1.04e-05	0.000102	CcSEcCtD
Diclofenac—Abdominal pain—Docetaxel—prostate cancer	1.04e-05	0.000102	CcSEcCtD
Diclofenac—Body temperature increased—Docetaxel—prostate cancer	1.04e-05	0.000102	CcSEcCtD
Diclofenac—Chills—Doxorubicin—prostate cancer	1.04e-05	0.000102	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Prednisone—prostate cancer	1.03e-05	0.000101	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—prostate cancer	1.03e-05	0.000101	CcSEcCtD
Diclofenac—Insomnia—Prednisone—prostate cancer	1.03e-05	0.000101	CcSEcCtD
Diclofenac—Vision blurred—Epirubicin—prostate cancer	1.03e-05	0.000101	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—prostate cancer	1.02e-05	0.0001	CcSEcCtD
Diclofenac—Paraesthesia—Prednisone—prostate cancer	1.02e-05	0.0001	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—prostate cancer	1.01e-05	9.94e-05	CcSEcCtD
Diclofenac—Urticaria—Capecitabine—prostate cancer	1.01e-05	9.93e-05	CcSEcCtD
Diclofenac—Ill-defined disorder—Epirubicin—prostate cancer	1.01e-05	9.9e-05	CcSEcCtD
Diclofenac—Body temperature increased—Capecitabine—prostate cancer	1.01e-05	9.88e-05	CcSEcCtD
Diclofenac—Abdominal pain—Capecitabine—prostate cancer	1.01e-05	9.88e-05	CcSEcCtD
Diclofenac—Vomiting—Etoposide—prostate cancer	1.01e-05	9.88e-05	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—prostate cancer	1.01e-05	9.87e-05	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—prostate cancer	1.01e-05	9.87e-05	CcSEcCtD
Diclofenac—Anaemia—Epirubicin—prostate cancer	1.01e-05	9.86e-05	CcSEcCtD
Diclofenac—Agitation—Epirubicin—prostate cancer	1e-05	9.81e-05	CcSEcCtD
Diclofenac—Dyspepsia—Prednisone—prostate cancer	9.99e-06	9.8e-05	CcSEcCtD
Diclofenac—Rash—Etoposide—prostate cancer	9.99e-06	9.8e-05	CcSEcCtD
Diclofenac—Dermatitis—Etoposide—prostate cancer	9.98e-06	9.79e-05	CcSEcCtD
Diclofenac—Headache—Etoposide—prostate cancer	9.92e-06	9.73e-05	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—prostate cancer	9.92e-06	9.73e-05	CcSEcCtD
Diclofenac—Tension—Doxorubicin—prostate cancer	9.88e-06	9.69e-05	CcSEcCtD
Diclofenac—Decreased appetite—Prednisone—prostate cancer	9.87e-06	9.68e-05	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—prostate cancer	9.86e-06	9.67e-05	CcSEcCtD
Diclofenac—Malaise—Epirubicin—prostate cancer	9.81e-06	9.62e-05	CcSEcCtD
Diclofenac—Fatigue—Prednisone—prostate cancer	9.79e-06	9.6e-05	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—prostate cancer	9.78e-06	9.59e-05	CcSEcCtD
Diclofenac—Vertigo—Epirubicin—prostate cancer	9.78e-06	9.59e-05	CcSEcCtD
Diclofenac—Syncope—Epirubicin—prostate cancer	9.76e-06	9.57e-05	CcSEcCtD
Diclofenac—Leukopenia—Epirubicin—prostate cancer	9.74e-06	9.55e-05	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—prostate cancer	9.74e-06	9.55e-05	CcSEcCtD
Diclofenac—Constipation—Prednisone—prostate cancer	9.71e-06	9.52e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Docetaxel—prostate cancer	9.7e-06	9.51e-05	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—prostate cancer	9.68e-06	9.49e-05	CcSEcCtD
Diclofenac—Palpitations—Epirubicin—prostate cancer	9.62e-06	9.43e-05	CcSEcCtD
Diclofenac—Loss of consciousness—Epirubicin—prostate cancer	9.56e-06	9.38e-05	CcSEcCtD
Diclofenac—Cough—Epirubicin—prostate cancer	9.49e-06	9.31e-05	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—prostate cancer	9.49e-06	9.3e-05	CcSEcCtD
Diclofenac—Asthenia—Docetaxel—prostate cancer	9.45e-06	9.26e-05	CcSEcCtD
Diclofenac—Convulsion—Epirubicin—prostate cancer	9.43e-06	9.25e-05	CcSEcCtD
Diclofenac—Nausea—Etoposide—prostate cancer	9.41e-06	9.23e-05	CcSEcCtD
Diclofenac—Hypertension—Epirubicin—prostate cancer	9.39e-06	9.21e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Capecitabine—prostate cancer	9.39e-06	9.21e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Prednisone—prostate cancer	9.36e-06	9.18e-05	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—prostate cancer	9.34e-06	9.16e-05	CcSEcCtD
Diclofenac—Pruritus—Docetaxel—prostate cancer	9.31e-06	9.13e-05	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—prostate cancer	9.3e-06	9.13e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Prednisone—prostate cancer	9.28e-06	9.11e-05	CcSEcCtD
Diclofenac—Chest pain—Epirubicin—prostate cancer	9.26e-06	9.08e-05	CcSEcCtD
Diclofenac—Myalgia—Epirubicin—prostate cancer	9.26e-06	9.08e-05	CcSEcCtD
Diclofenac—Arthralgia—Epirubicin—prostate cancer	9.26e-06	9.08e-05	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—prostate cancer	9.25e-06	9.07e-05	CcSEcCtD
Diclofenac—Anxiety—Epirubicin—prostate cancer	9.23e-06	9.05e-05	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	9.2e-06	9.02e-05	CcSEcCtD
Diclofenac—Discomfort—Epirubicin—prostate cancer	9.15e-06	8.98e-05	CcSEcCtD
Diclofenac—Asthenia—Capecitabine—prostate cancer	9.15e-06	8.97e-05	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—prostate cancer	9.08e-06	8.9e-05	CcSEcCtD
Diclofenac—Dry mouth—Epirubicin—prostate cancer	9.06e-06	8.88e-05	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—prostate cancer	9.04e-06	8.87e-05	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—prostate cancer	9.03e-06	8.85e-05	CcSEcCtD
Diclofenac—Urticaria—Prednisone—prostate cancer	9.02e-06	8.85e-05	CcSEcCtD
Diclofenac—Pruritus—Capecitabine—prostate cancer	9.02e-06	8.84e-05	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—prostate cancer	9.01e-06	8.84e-05	CcSEcCtD
Diclofenac—Diarrhoea—Docetaxel—prostate cancer	9.01e-06	8.83e-05	CcSEcCtD
Diclofenac—Abdominal pain—Prednisone—prostate cancer	8.98e-06	8.8e-05	CcSEcCtD
Diclofenac—Body temperature increased—Prednisone—prostate cancer	8.98e-06	8.8e-05	CcSEcCtD
Diclofenac—Confusional state—Epirubicin—prostate cancer	8.95e-06	8.78e-05	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—prostate cancer	8.9e-06	8.73e-05	CcSEcCtD
Diclofenac—Oedema—Epirubicin—prostate cancer	8.88e-06	8.71e-05	CcSEcCtD
Diclofenac—Anaphylactic shock—Epirubicin—prostate cancer	8.88e-06	8.71e-05	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—prostate cancer	8.85e-06	8.68e-05	CcSEcCtD
Diclofenac—Infection—Epirubicin—prostate cancer	8.82e-06	8.65e-05	CcSEcCtD
Diclofenac—Cough—Doxorubicin—prostate cancer	8.78e-06	8.62e-05	CcSEcCtD
Diclofenac—Shock—Epirubicin—prostate cancer	8.74e-06	8.57e-05	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—prostate cancer	8.72e-06	8.55e-05	CcSEcCtD
Diclofenac—Diarrhoea—Capecitabine—prostate cancer	8.72e-06	8.55e-05	CcSEcCtD
Diclofenac—Nervous system disorder—Epirubicin—prostate cancer	8.71e-06	8.54e-05	CcSEcCtD
Diclofenac—Dizziness—Docetaxel—prostate cancer	8.71e-06	8.54e-05	CcSEcCtD
Diclofenac—Thrombocytopenia—Epirubicin—prostate cancer	8.69e-06	8.53e-05	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—prostate cancer	8.69e-06	8.52e-05	CcSEcCtD
Diclofenac—Tachycardia—Epirubicin—prostate cancer	8.67e-06	8.5e-05	CcSEcCtD
Diclofenac—Skin disorder—Epirubicin—prostate cancer	8.63e-06	8.46e-05	CcSEcCtD
Diclofenac—Hyperhidrosis—Epirubicin—prostate cancer	8.58e-06	8.42e-05	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—prostate cancer	8.57e-06	8.41e-05	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—prostate cancer	8.57e-06	8.41e-05	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—prostate cancer	8.57e-06	8.41e-05	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—prostate cancer	8.54e-06	8.38e-05	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	8.51e-06	8.35e-05	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—prostate cancer	8.47e-06	8.3e-05	CcSEcCtD
Diclofenac—Anorexia—Epirubicin—prostate cancer	8.46e-06	8.3e-05	CcSEcCtD
Diclofenac—Dizziness—Capecitabine—prostate cancer	8.43e-06	8.27e-05	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—prostate cancer	8.38e-06	8.22e-05	CcSEcCtD
Diclofenac—Vomiting—Docetaxel—prostate cancer	8.37e-06	8.21e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Prednisone—prostate cancer	8.36e-06	8.2e-05	CcSEcCtD
Diclofenac—Rash—Docetaxel—prostate cancer	8.3e-06	8.14e-05	CcSEcCtD
Diclofenac—Hypotension—Epirubicin—prostate cancer	8.3e-06	8.14e-05	CcSEcCtD
Diclofenac—Dermatitis—Docetaxel—prostate cancer	8.29e-06	8.13e-05	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—prostate cancer	8.28e-06	8.12e-05	CcSEcCtD
Diclofenac—Headache—Docetaxel—prostate cancer	8.25e-06	8.09e-05	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—prostate cancer	8.22e-06	8.06e-05	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—prostate cancer	8.22e-06	8.06e-05	CcSEcCtD
Diclofenac—Infection—Doxorubicin—prostate cancer	8.16e-06	8.01e-05	CcSEcCtD
Diclofenac—Asthenia—Prednisone—prostate cancer	8.15e-06	7.99e-05	CcSEcCtD
Diclofenac—Vomiting—Capecitabine—prostate cancer	8.1e-06	7.95e-05	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Epirubicin—prostate cancer	8.09e-06	7.93e-05	CcSEcCtD
Diclofenac—Shock—Doxorubicin—prostate cancer	8.08e-06	7.93e-05	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—prostate cancer	8.06e-06	7.9e-05	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—prostate cancer	8.04e-06	7.89e-05	CcSEcCtD
Diclofenac—Rash—Capecitabine—prostate cancer	8.04e-06	7.88e-05	CcSEcCtD
Diclofenac—Pruritus—Prednisone—prostate cancer	8.03e-06	7.88e-05	CcSEcCtD
Diclofenac—Insomnia—Epirubicin—prostate cancer	8.03e-06	7.88e-05	CcSEcCtD
Diclofenac—Dermatitis—Capecitabine—prostate cancer	8.03e-06	7.87e-05	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—prostate cancer	8.02e-06	7.86e-05	CcSEcCtD
Diclofenac—Headache—Capecitabine—prostate cancer	7.99e-06	7.83e-05	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—prostate cancer	7.98e-06	7.83e-05	CcSEcCtD
Diclofenac—Paraesthesia—Epirubicin—prostate cancer	7.97e-06	7.82e-05	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—prostate cancer	7.94e-06	7.79e-05	CcSEcCtD
Diclofenac—Dyspnoea—Epirubicin—prostate cancer	7.92e-06	7.76e-05	CcSEcCtD
Diclofenac—Somnolence—Epirubicin—prostate cancer	7.89e-06	7.74e-05	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—prostate cancer	7.83e-06	7.68e-05	CcSEcCtD
Diclofenac—Nausea—Docetaxel—prostate cancer	7.82e-06	7.67e-05	CcSEcCtD
Diclofenac—Dyspepsia—Epirubicin—prostate cancer	7.82e-06	7.67e-05	CcSEcCtD
Diclofenac—Diarrhoea—Prednisone—prostate cancer	7.77e-06	7.62e-05	CcSEcCtD
Diclofenac—Decreased appetite—Epirubicin—prostate cancer	7.72e-06	7.57e-05	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—prostate cancer	7.68e-06	7.53e-05	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Epirubicin—prostate cancer	7.67e-06	7.52e-05	CcSEcCtD
Diclofenac—Fatigue—Epirubicin—prostate cancer	7.66e-06	7.51e-05	CcSEcCtD
Diclofenac—Constipation—Epirubicin—prostate cancer	7.59e-06	7.45e-05	CcSEcCtD
Diclofenac—Pain—Epirubicin—prostate cancer	7.59e-06	7.45e-05	CcSEcCtD
Diclofenac—Nausea—Capecitabine—prostate cancer	7.57e-06	7.43e-05	CcSEcCtD
Diclofenac—Dizziness—Prednisone—prostate cancer	7.51e-06	7.36e-05	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—prostate cancer	7.49e-06	7.34e-05	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—prostate cancer	7.43e-06	7.29e-05	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—prostate cancer	7.38e-06	7.24e-05	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—prostate cancer	7.33e-06	7.18e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Epirubicin—prostate cancer	7.32e-06	7.18e-05	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—prostate cancer	7.3e-06	7.16e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Epirubicin—prostate cancer	7.26e-06	7.12e-05	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—prostate cancer	7.23e-06	7.09e-05	CcSEcCtD
Diclofenac—Vomiting—Prednisone—prostate cancer	7.22e-06	7.08e-05	CcSEcCtD
Diclofenac—Rash—Prednisone—prostate cancer	7.16e-06	7.02e-05	CcSEcCtD
Diclofenac—Dermatitis—Prednisone—prostate cancer	7.15e-06	7.01e-05	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—prostate cancer	7.14e-06	7e-05	CcSEcCtD
Diclofenac—Headache—Prednisone—prostate cancer	7.11e-06	6.98e-05	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—prostate cancer	7.09e-06	6.96e-05	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—prostate cancer	7.08e-06	6.95e-05	CcSEcCtD
Diclofenac—Urticaria—Epirubicin—prostate cancer	7.05e-06	6.92e-05	CcSEcCtD
Diclofenac—Pain—Doxorubicin—prostate cancer	7.03e-06	6.89e-05	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—prostate cancer	7.03e-06	6.89e-05	CcSEcCtD
Diclofenac—Abdominal pain—Epirubicin—prostate cancer	7.02e-06	6.88e-05	CcSEcCtD
Diclofenac—Body temperature increased—Epirubicin—prostate cancer	7.02e-06	6.88e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—prostate cancer	6.77e-06	6.64e-05	CcSEcCtD
Diclofenac—Nausea—Prednisone—prostate cancer	6.74e-06	6.61e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—prostate cancer	6.72e-06	6.59e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Epirubicin—prostate cancer	6.54e-06	6.42e-05	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—prostate cancer	6.53e-06	6.4e-05	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—prostate cancer	6.5e-06	6.37e-05	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—prostate cancer	6.5e-06	6.37e-05	CcSEcCtD
Diclofenac—Asthenia—Epirubicin—prostate cancer	6.37e-06	6.25e-05	CcSEcCtD
Diclofenac—Pruritus—Epirubicin—prostate cancer	6.28e-06	6.16e-05	CcSEcCtD
Diclofenac—Diarrhoea—Epirubicin—prostate cancer	6.08e-06	5.96e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—prostate cancer	6.05e-06	5.94e-05	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—prostate cancer	5.89e-06	5.78e-05	CcSEcCtD
Diclofenac—Dizziness—Epirubicin—prostate cancer	5.87e-06	5.76e-05	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—prostate cancer	5.81e-06	5.7e-05	CcSEcCtD
Diclofenac—Vomiting—Epirubicin—prostate cancer	5.65e-06	5.54e-05	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—prostate cancer	5.62e-06	5.51e-05	CcSEcCtD
Diclofenac—Rash—Epirubicin—prostate cancer	5.6e-06	5.49e-05	CcSEcCtD
Diclofenac—Dermatitis—Epirubicin—prostate cancer	5.59e-06	5.49e-05	CcSEcCtD
Diclofenac—Headache—Epirubicin—prostate cancer	5.56e-06	5.46e-05	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—prostate cancer	5.43e-06	5.33e-05	CcSEcCtD
Diclofenac—Nausea—Epirubicin—prostate cancer	5.27e-06	5.17e-05	CcSEcCtD
Diclofenac—Vomiting—Doxorubicin—prostate cancer	5.22e-06	5.12e-05	CcSEcCtD
Diclofenac—Rash—Doxorubicin—prostate cancer	5.18e-06	5.08e-05	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—prostate cancer	5.18e-06	5.08e-05	CcSEcCtD
Diclofenac—Headache—Doxorubicin—prostate cancer	5.15e-06	5.05e-05	CcSEcCtD
Diclofenac—Nausea—Doxorubicin—prostate cancer	4.88e-06	4.79e-05	CcSEcCtD
Diclofenac—CYP2C9—Metabolism—GSTP1—prostate cancer	5.31e-07	6.67e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP3A4—prostate cancer	5.3e-07	6.66e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—MTHFR—prostate cancer	5.29e-07	6.66e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TYMS—prostate cancer	5.28e-07	6.64e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CB—prostate cancer	5.28e-07	6.63e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.27e-07	6.63e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—JAK2—prostate cancer	5.27e-07	6.62e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—MTHFR—prostate cancer	5.26e-07	6.62e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CG—prostate cancer	5.25e-07	6.61e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—LPL—prostate cancer	5.25e-07	6.6e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—prostate cancer	5.24e-07	6.58e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—prostate cancer	5.23e-07	6.57e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ITPR1—prostate cancer	5.22e-07	6.56e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTM1—prostate cancer	5.22e-07	6.56e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1B1—prostate cancer	5.21e-07	6.55e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HPGDS—prostate cancer	5.21e-07	6.54e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARA—prostate cancer	5.19e-07	6.53e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—INS—prostate cancer	5.18e-07	6.51e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2C19—prostate cancer	5.17e-07	6.5e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARA—prostate cancer	5.17e-07	6.49e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CG—prostate cancer	5.15e-07	6.47e-06	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—EP300—prostate cancer	5.14e-07	6.47e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MDM2—prostate cancer	5.14e-07	6.46e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.13e-07	6.45e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—LPL—prostate cancer	5.12e-07	6.44e-06	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—prostate cancer	5.1e-07	6.41e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.09e-07	6.4e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP1A1—prostate cancer	5.07e-07	6.37e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CREBBP—prostate cancer	5.07e-07	6.37e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB2—prostate cancer	5.07e-07	6.37e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ACHE—prostate cancer	5.05e-07	6.35e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTT1—prostate cancer	5.05e-07	6.35e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GGT1—prostate cancer	5.05e-07	6.35e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ERCC2—prostate cancer	5.03e-07	6.32e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CB—prostate cancer	5e-07	6.29e-06	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—prostate cancer	4.99e-07	6.28e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.99e-07	6.27e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—INS—prostate cancer	4.97e-07	6.25e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NCOA1—prostate cancer	4.97e-07	6.25e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP1A1—prostate cancer	4.95e-07	6.22e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—prostate cancer	4.95e-07	6.22e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TYMS—prostate cancer	4.93e-07	6.2e-06	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—prostate cancer	4.93e-07	6.2e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ERCC2—prostate cancer	4.91e-07	6.17e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP19A1—prostate cancer	4.9e-07	6.16e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CAV1—prostate cancer	4.88e-07	6.14e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTM1—prostate cancer	4.88e-07	6.13e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—prostate cancer	4.87e-07	6.13e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CREBBP—prostate cancer	4.87e-07	6.12e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—INS—prostate cancer	4.87e-07	6.12e-06	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—prostate cancer	4.86e-07	6.1e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CAV1—prostate cancer	4.86e-07	6.1e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.85e-07	6.1e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CG—prostate cancer	4.85e-07	6.1e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PRKACB—prostate cancer	4.83e-07	6.07e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CD—prostate cancer	4.81e-07	6.04e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—LPL—prostate cancer	4.79e-07	6.02e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.78e-07	6.01e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CREBBP—prostate cancer	4.77e-07	6e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—RXRA—prostate cancer	4.73e-07	5.95e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—MTHFR—prostate cancer	4.73e-07	5.94e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—prostate cancer	4.72e-07	5.93e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1B—prostate cancer	4.69e-07	5.9e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.67e-07	5.87e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.64e-07	5.83e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARA—prostate cancer	4.64e-07	5.83e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP1A1—prostate cancer	4.62e-07	5.81e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CD—prostate cancer	4.62e-07	5.81e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—MTHFR—prostate cancer	4.61e-07	5.8e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.6e-07	5.78e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—INS—prostate cancer	4.59e-07	5.77e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ERCC2—prostate cancer	4.58e-07	5.76e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTEN—prostate cancer	4.56e-07	5.73e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—COMT—prostate cancer	4.56e-07	5.73e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NCOA2—prostate cancer	4.55e-07	5.72e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—prostate cancer	4.54e-07	5.71e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—NOS3—prostate cancer	4.54e-07	5.71e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTP1—prostate cancer	4.53e-07	5.7e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARA—prostate cancer	4.53e-07	5.69e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CD—prostate cancer	4.52e-07	5.69e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CREBBP—prostate cancer	4.5e-07	5.66e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ITPR1—prostate cancer	4.46e-07	5.61e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CG—prostate cancer	4.45e-07	5.59e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CTNNB1—prostate cancer	4.44e-07	5.58e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CG—prostate cancer	4.42e-07	5.56e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.39e-07	5.51e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—NOS3—prostate cancer	4.36e-07	5.48e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CAV1—prostate cancer	4.36e-07	5.48e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—EP300—prostate cancer	4.35e-07	5.47e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC5A5—prostate cancer	4.34e-07	5.46e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1A—prostate cancer	4.33e-07	5.45e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTEN—prostate cancer	4.32e-07	5.43e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—prostate cancer	4.32e-07	5.43e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—MTHFR—prostate cancer	4.31e-07	5.42e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—NOS3—prostate cancer	4.27e-07	5.37e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CD—prostate cancer	4.27e-07	5.36e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CAV1—prostate cancer	4.25e-07	5.35e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2E1—prostate cancer	4.24e-07	5.33e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARA—prostate cancer	4.23e-07	5.31e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TYMS—prostate cancer	4.22e-07	5.3e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—INS—prostate cancer	4.21e-07	5.29e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NQO1—prostate cancer	4.2e-07	5.27e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CB—prostate cancer	4.19e-07	5.27e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—INS—prostate cancer	4.19e-07	5.26e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTM1—prostate cancer	4.17e-07	5.24e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.16e-07	5.24e-06	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—prostate cancer	4.16e-07	5.23e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TH—prostate cancer	4.14e-07	5.2e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CREBBP—prostate cancer	4.12e-07	5.18e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EP300—prostate cancer	4.12e-07	5.18e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CREBBP—prostate cancer	4.1e-07	5.16e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—LPL—prostate cancer	4.09e-07	5.14e-06	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—prostate cancer	4.08e-07	5.13e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—NOS3—prostate cancer	4.03e-07	5.06e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CB—prostate cancer	4.03e-07	5.06e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—prostate cancer	4.02e-07	5.06e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1B1—prostate cancer	4.02e-07	5.06e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SRC—prostate cancer	4.01e-07	5.04e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—prostate cancer	3.99e-07	5.02e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—prostate cancer	3.98e-07	5.01e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CAV1—prostate cancer	3.97e-07	5e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CG—prostate cancer	3.97e-07	4.99e-06	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—prostate cancer	3.97e-07	4.99e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.95e-07	4.97e-06	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—prostate cancer	3.95e-07	4.96e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CB—prostate cancer	3.94e-07	4.96e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ERCC2—prostate cancer	3.92e-07	4.92e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CD—prostate cancer	3.91e-07	4.92e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—prostate cancer	3.91e-07	4.91e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GGT1—prostate cancer	3.9e-07	4.9e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CD—prostate cancer	3.89e-07	4.89e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CG—prostate cancer	3.88e-07	4.87e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—prostate cancer	3.87e-07	4.86e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NCOA1—prostate cancer	3.84e-07	4.82e-06	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—prostate cancer	3.81e-07	4.78e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.8e-07	4.77e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.78e-07	4.75e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—INS—prostate cancer	3.76e-07	4.72e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CB—prostate cancer	3.72e-07	4.67e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—prostate cancer	3.71e-07	4.67e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NOS3—prostate cancer	3.69e-07	4.64e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—prostate cancer	3.68e-07	4.63e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—MTHFR—prostate cancer	3.68e-07	4.63e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CREBBP—prostate cancer	3.68e-07	4.63e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NOS3—prostate cancer	3.67e-07	4.62e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—INS—prostate cancer	3.67e-07	4.61e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—RXRA—prostate cancer	3.65e-07	4.59e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CG—prostate cancer	3.62e-07	4.55e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PTEN—prostate cancer	3.62e-07	4.55e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARA—prostate cancer	3.61e-07	4.54e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CREBBP—prostate cancer	3.59e-07	4.52e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—prostate cancer	3.59e-07	4.52e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFB1—prostate cancer	3.58e-07	4.5e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—COMT—prostate cancer	3.52e-07	4.42e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—prostate cancer	3.51e-07	4.42e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTP1—prostate cancer	3.5e-07	4.4e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CD—prostate cancer	3.49e-07	4.39e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTEN—prostate cancer	3.48e-07	4.37e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—EP300—prostate cancer	3.45e-07	4.34e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ITPR1—prostate cancer	3.44e-07	4.33e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—INS—prostate cancer	3.43e-07	4.31e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CB—prostate cancer	3.41e-07	4.29e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTEN—prostate cancer	3.41e-07	4.28e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CD—prostate cancer	3.41e-07	4.28e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CAV1—prostate cancer	3.4e-07	4.27e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CB—prostate cancer	3.39e-07	4.26e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—prostate cancer	3.38e-07	4.25e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—prostate cancer	3.36e-07	4.22e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CREBBP—prostate cancer	3.36e-07	4.22e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—prostate cancer	3.32e-07	4.17e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—EP300—prostate cancer	3.32e-07	4.17e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NOS3—prostate cancer	3.3e-07	4.14e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TYMS—prostate cancer	3.25e-07	4.09e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—EP300—prostate cancer	3.25e-07	4.09e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.25e-07	4.08e-06	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—prostate cancer	3.22e-07	4.05e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NOS3—prostate cancer	3.22e-07	4.04e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—prostate cancer	3.22e-07	4.04e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTM1—prostate cancer	3.22e-07	4.04e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTEN—prostate cancer	3.21e-07	4.04e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CD—prostate cancer	3.18e-07	4e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—LPL—prostate cancer	3.16e-07	3.97e-06	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—prostate cancer	3.11e-07	3.91e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CG—prostate cancer	3.09e-07	3.89e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—EP300—prostate cancer	3.06e-07	3.85e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—prostate cancer	3.05e-07	3.83e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.05e-07	3.83e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CB—prostate cancer	3.04e-07	3.82e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ERCC2—prostate cancer	3.02e-07	3.8e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—prostate cancer	3.01e-07	3.79e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NOS3—prostate cancer	3.01e-07	3.78e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CB—prostate cancer	2.97e-07	3.73e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTEN—prostate cancer	2.95e-07	3.7e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—prostate cancer	2.94e-07	3.7e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTEN—prostate cancer	2.93e-07	3.68e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—INS—prostate cancer	2.93e-07	3.68e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CREBBP—prostate cancer	2.87e-07	3.61e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MTHFR—prostate cancer	2.84e-07	3.57e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—EP300—prostate cancer	2.81e-07	3.53e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—EP300—prostate cancer	2.79e-07	3.51e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARA—prostate cancer	2.79e-07	3.5e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.77e-07	3.49e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—prostate cancer	2.75e-07	3.46e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.72e-07	3.42e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—prostate cancer	2.7e-07	3.39e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTEN—prostate cancer	2.63e-07	3.31e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—prostate cancer	2.63e-07	3.3e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CAV1—prostate cancer	2.62e-07	3.3e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NOS3—prostate cancer	2.57e-07	3.23e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTEN—prostate cancer	2.57e-07	3.23e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—prostate cancer	2.55e-07	3.21e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—EP300—prostate cancer	2.51e-07	3.15e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—prostate cancer	2.49e-07	3.13e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—prostate cancer	2.45e-07	3.09e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—EP300—prostate cancer	2.45e-07	3.08e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—prostate cancer	2.4e-07	3.02e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTEN—prostate cancer	2.4e-07	3.01e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.39e-07	3e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CB—prostate cancer	2.37e-07	2.98e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—prostate cancer	2.35e-07	2.95e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—EP300—prostate cancer	2.29e-07	2.87e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—prostate cancer	2.27e-07	2.85e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—INS—prostate cancer	2.26e-07	2.84e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CREBBP—prostate cancer	2.21e-07	2.78e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.1e-07	2.64e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—prostate cancer	2.09e-07	2.62e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—prostate cancer	2.08e-07	2.61e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—prostate cancer	2.07e-07	2.6e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTEN—prostate cancer	2.05e-07	2.58e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—prostate cancer	2.01e-07	2.52e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NOS3—prostate cancer	1.98e-07	2.49e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—prostate cancer	1.96e-07	2.47e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—EP300—prostate cancer	1.95e-07	2.46e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.85e-07	2.33e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—prostate cancer	1.85e-07	2.33e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.83e-07	2.3e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—prostate cancer	1.81e-07	2.28e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—prostate cancer	1.81e-07	2.28e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—prostate cancer	1.7e-07	2.13e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.69e-07	2.13e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—prostate cancer	1.69e-07	2.12e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTEN—prostate cancer	1.58e-07	1.99e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—prostate cancer	1.52e-07	1.9e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—EP300—prostate cancer	1.51e-07	1.9e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—prostate cancer	1.48e-07	1.86e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.45e-07	1.82e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—prostate cancer	1.38e-07	1.74e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—prostate cancer	1.18e-07	1.48e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.12e-07	1.4e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—prostate cancer	9.11e-08	1.15e-06	CbGpPWpGaD
